- Home
- AVTX vs SVAC Comparison
AVTX vs SVAC Comparison
Compare AVTX & SVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.95
Company Overview
Basic Information| Metric | AVTX | SVAC |
|---|---|---|
| Founded | 2011 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.9M | 312.2M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | SVAC |
|---|---|---|
| Price | $14.95 | $10.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $36.80 | N/A |
| AVG Volume (30 Days) | ★ 745.9K | 94.1K |
| Earning Date | 03-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.39 | $10.06 |
| 52 Week High | $20.72 | $12.00 |
Technical Indicators
Market Signals| Indicator | AVTX | SVAC |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 38.15 |
| Support Level | $13.38 | $10.15 |
| Resistance Level | $16.40 | $10.28 |
| Average True Range (ATR) | 1.08 | 0.04 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 48.03 | 21.43 |
Price Performance
Historical Comparison AVTX
SVAC
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About SVAC Spring Valley Acquisition Corp. III Class A Ordinary Shares
Spring Valley Acquisition Corp III is a blank check company.